Satisfaction and anxiety are improved with the use of an easy-to-read informed consent document: a randomized multi-group study

Li Liu, MD

University of Pennsylvania Cancer
Last Modified: May 12, 2001

Share article


Presenter: P. C. Raich
Affiliation: AMC Cancer Research Center, Denver, CO

Background:

    Informed consent is a process in which the patient is given all the information needed to decide whether to participate in a clincal trial. The signing of the informed consent document by both the patient and the investigator is the written verification of this process. Readability of most of the consents remains a problem for the US population in which half has reading skills at an 8th grade level or below.

Materials and Methods:

  • 226 patients who were randomly assigned to either standard consent form (13th grade level) or an easy to read form (8th grade level) were evaluated
  • Multiple institution study including 46 sites involved with three clinical trials from the NCCTG, ECOG, and CALGB.
  • Comprehension of the consent, anxiety associated with the process, and satisfaction with the process were all evaluated.

Results:

  • Comprehension of consent content was similar between two groups
  • More satisfaction and decreased anxiety were observed in easy
  • to
  • read group

Authors' Conclusions

  • Easy readability was associated with enhanced satisfaction and reduced anxiety
  • Participation of clinical trials maybe enhanced by patient's satisfaction and less anxiety with informed consent process

Clinical/Scientific Implications:

  • The signing of the informed consent form does not, however, end the process of consent
  • The investigator is obligated to continue to provide relevant information to the subject, answer questions, and ensure understanding throughout the duration of the study
  • Continued education of patients who are enrolled in the clinical trials may also play a positive role in patient's satisfaction

Saturday | Sunday | Monday | Tuesday

OncoLink ASCO 2001 coverage is provided by an unrestricted educational grant from Amgen


News
Randomized Controlled HCC Screening Trial Not Feasible

Dec 8, 2011 - A randomized controlled trial of hepatocellular carcinoma (HCC) screening is not feasible for informed patients with cirrhosis; and small HCC detection is not improved by ultrasonographic screening every three versus six months, according to two studies published in the December issue of Hepatology.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More